KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Hims & Hers Health (HIMS) Operating Expenses (2020 - 2025)

Historic Operating Expenses for Hims & Hers Health (HIMS) over the last 6 years, with Q3 2025 value amounting to $430.3 million.

  • Hims & Hers Health's Operating Expenses rose 4559.51% to $430.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 billion, marking a year-over-year increase of 5998.64%. This contributed to the annual value of $1.1 billion for FY2024, which is 4927.85% up from last year.
  • As of Q3 2025, Hims & Hers Health's Operating Expenses stood at $430.3 million, which was up 4559.51% from $389.5 million recorded in Q2 2025.
  • In the past 5 years, Hims & Hers Health's Operating Expenses registered a high of $430.3 million during Q3 2025, and its lowest value of $64.7 million during Q2 2021.
  • In the last 5 years, Hims & Hers Health's Operating Expenses had a median value of $179.4 million in 2023 and averaged $202.4 million.
  • Its Operating Expenses has fluctuated over the past 5 years, first skyrocketed by 23034.99% in 2021, then soared by 340.53% in 2022.
  • Over the past 5 years, Hims & Hers Health's Operating Expenses (Quarter) stood at $83.7 million in 2021, then soared by 72.05% to $143.9 million in 2022, then surged by 42.04% to $204.5 million in 2023, then surged by 71.65% to $350.9 million in 2024, then rose by 22.6% to $430.3 million in 2025.
  • Its last three reported values are $430.3 million in Q3 2025, $389.5 million for Q2 2025, and $372.8 million during Q1 2025.